From: Bioequivalence of levamlodipine besylate tablets in healthy Chinese subjects: a single-dose and two-period crossover randomized study
Parameter
T/R (%)
90% CIs
Power (%)
Cmax
95.41
89.59–101.61%
99.87
AUC0–t
91.28
87.83–94.87%
100.00
AUC0–∞
89.81
86.28–93.49%
99.92